| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1016352013 |
| P356 | DOI | 10.1007/S10620-015-3646-4 |
| P698 | PubMed publication ID | 25840920 |
| P2093 | author name string | Masakazu Yashiro | |
| P2860 | cites work | Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis | Q22122362 |
| Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee | Q22242348 | ||
| Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease | Q22242636 | ||
| A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease | Q22251291 | ||
| Molecular epidemiology of human cancer: contribution of mutation spectra studies of tumor suppressor genes | Q77343348 | ||
| The APC/beta-catenin pathway in ulcerative colitis-related colorectal carcinomas: a mutational analysis | Q77838993 | ||
| P53 and beta catenin expression in chronic ulcerative colitis--associated polypoid dysplasia and sporadic adenomas: an immunohistochemical study | Q78093501 | ||
| Appendectomy is followed by increased risk of Crohn's disease | Q78746035 | ||
| Small intestinal adenocarcinoma in Crohn's disease: a case-control study | Q79856050 | ||
| Smoking habit and load influence age at diagnosis and disease extent in ulcerative colitis | Q79878476 | ||
| Colorectal neoplasia in Crohn's colitis: a retrospective comparative study with ulcerative colitis | Q80062760 | ||
| The effect of acute psychologic stress on systemic and rectal mucosal measures of inflammation in ulcerative colitis | Q80063664 | ||
| Hypermethylation of p14 (ARF) may be predictive of colitic cancer in patients with ulcerative colitis | Q80706617 | ||
| Ulcerative colitis-associated colorectal cancer is frequently associated with the microsatellite instability pathway | Q81436373 | ||
| Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease | Q81600128 | ||
| AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease | Q82829771 | ||
| European evidence-based Consensus on the management of ulcerative colitis: Special situations | Q82963217 | ||
| Epigenetic imprinting by commensal probiotics inhibits the IL-23/IL-17 axis in an in vitro model of the intestinal mucosal immune system | Q84451441 | ||
| Association of circulating vitamin D concentrations with intestinal but not systemic inflammation in inflammatory bowel disease | Q86492985 | ||
| Risk and location of cancer in patients with preoperative colitis-associated dysplasia undergoing proctocolectomy | Q86582085 | ||
| Mutagenicity and repair of oxidative DNA damage: insights from studies using defined lesions | Q95807087 | ||
| Diet activity, and lifestyle associations with p53 mutations in colon tumors | Q74244794 | ||
| Genetic alterations in chronic ulcerative colitis-associated adenoma-like DALMs are similar to non-colitic sporadic adenomas | Q74284388 | ||
| Telomere shortening in the colonic mucosa of patients with ulcerative colitis | Q74766407 | ||
| Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis | Q77220460 | ||
| Psychological interventions for treatment of inflammatory bowel disease | Q24234176 | ||
| Growth suppression by p16ink4 requires functional retinoblastoma protein | Q24317567 | ||
| Update on inflammatory bowel disease in patients with primary sclerosing cholangitis | Q24567496 | ||
| A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses | Q24630221 | ||
| Cancer in inflammatory bowel disease | Q24648315 | ||
| Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis | Q24656576 | ||
| The risk of colorectal cancer in ulcerative colitis: a meta-analysis | Q24669747 | ||
| Suppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligands | Q24810709 | ||
| Potential association between TLR4 and chitinase 3-like 1 (CHI3L1/YKL-40) signaling on colonic epithelial cells in inflammatory bowel disease and colitis-associated cancer | Q26853189 | ||
| Microbiota impact on the epigenetic regulation of colorectal cancer | Q27028132 | ||
| A genetic model for colorectal tumorigenesis | Q27860582 | ||
| Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease | Q27860821 | ||
| Cancer-related inflammation | Q27860907 | ||
| 5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study | Q28182523 | ||
| Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study | Q28218907 | ||
| Identification of a chromosome 18q gene that is altered in colorectal cancers | Q28274172 | ||
| APC mutations occur early during colorectal tumorigenesis | Q28274764 | ||
| Smoking and inflammatory bowel disease: a meta-analysis | Q28275088 | ||
| Genetic alterations during colorectal-tumor development | Q28281200 | ||
| Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene | Q28593669 | ||
| Implications of systemic dysfunction for the etiology of malignancy | Q28708952 | ||
| Relationship between the polymorphism of tumor necrosis factor-α-308 G>A and susceptibility to inflammatory bowel diseases and colorectal cancer: a meta-analysis | Q28741818 | ||
| Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis | Q29547656 | ||
| Interleukin-10-deficient mice develop chronic enterocolitis | Q29547881 | ||
| IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer | Q29614594 | ||
| Gut Microbiota in Health and Disease | Q29616812 | ||
| Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences | Q29617565 | ||
| Psychological stress in IBD: new insights into pathogenic and therapeutic implications | Q30493180 | ||
| Mesalamine blocks tumor necrosis factor growth inhibition and nuclear factor kappaB activation in mouse colonocytes | Q30638019 | ||
| Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis | Q31933357 | ||
| Recent trends in library design: 'rational design' revisited | Q33329844 | ||
| Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee | Q33523446 | ||
| Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). | Q37739029 | ||
| Intestinal inflammation and cancer | Q37870432 | ||
| Nonlinear reduction in risk for colorectal cancer by fruit and vegetable intake based on meta-analysis of prospective studies | Q37877803 | ||
| Inflammation, DNA methylation and colitis-associated cancer | Q37974887 | ||
| Oxidative stress in ulcerative colitis: an old concept but a new concern | Q38031537 | ||
| Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations | Q38049779 | ||
| Overview of molecular pathways in inflammatory bowel disease associated with colorectal cancer development. | Q38061356 | ||
| Dysplastic lesions in inflammatory bowel disease: molecular pathogenesis to morphology | Q38085633 | ||
| 5-Aminosalicylic acid and chemoprevention: does it work? | Q38136963 | ||
| Has the risk of colorectal cancer in inflammatory bowel disease decreased? | Q38166711 | ||
| Microscopic features of colorectal neoplasia in inflammatory bowel diseases | Q38201709 | ||
| Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years | Q38433080 | ||
| Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies | Q38434726 | ||
| Decreasing time-trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease | Q38450732 | ||
| Associations between dietary intake and Ki-ras mutations in colon tumors: a population-based study. | Q38462731 | ||
| Ulcerative colitis and colon cancer | Q39564261 | ||
| Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced chemokine release in both TRAIL-resistant and TRAIL-sensitive cells via nuclear factor kappa B. | Q39899167 | ||
| Colorectal cancer risk in Crohn's disease | Q40112425 | ||
| Dysplasia and Malignancy in Inflammatory Bowel Disease | Q40177007 | ||
| Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine. | Q40235770 | ||
| Mortality in ulcerative colitis | Q40340503 | ||
| Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? | Q40619445 | ||
| The retinoblastoma gene: role in cell cycle control and cell differentiation | Q40856541 | ||
| Colorectal cancer and nonsteroidal anti-inflammatory drugs. | Q40912955 | ||
| Retinoblastoma protein family in cell cycle and cancer: a review | Q41168285 | ||
| Chronic Inflammation, Colorectal Cancer and Gene Polymorphisms | Q41203019 | ||
| Genetic alterations in ulcerative colitis-associated neoplasia focusing on APC, K-ras gene and microsatellite instability | Q41707387 | ||
| Colorectal cancer prevention in ulcerative colitis: a case-control study. | Q41716716 | ||
| Decreased expression of CD44, alpha-catenin, and deleted colon carcinoma and altered expression of beta-catenin in ulcerative colitis-associated dysplasia and carcinoma, as compared with sporadic colon neoplasms | Q41756853 | ||
| Clinical and pathological associations with allelic loss in colorectal carcinoma [corrected]. | Q41789530 | ||
| Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer | Q42114865 | ||
| Clues to the pathogenesis of familial colorectal cancer | Q42622043 | ||
| Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. | Q42793428 | ||
| Defective hMSH2/hMLH1 protein expression is seen infrequently in ulcerative colitis associated colorectal cancers | Q43086535 | ||
| Cancer in Crohn's disease: dispelling the myths | Q43215039 | ||
| Chronic stress induces mast cell-dependent bacterial adherence and initiates mucosal inflammation in rat intestine | Q43357446 | ||
| Dietary intake and microsatellite instability in colon tumors | Q43690857 | ||
| Accelerated age-related CpG island methylation in ulcerative colitis | Q43828587 | ||
| Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis | Q44387821 | ||
| Perinatal risk factors for inflammatory bowel disease: a case-control study | Q44438106 | ||
| Intestinal and extra-intestinal cancer in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark | Q44776677 | ||
| Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan. | Q45242450 | ||
| Inducible nitric oxide synthase-dependent DNA damage in mouse model of inflammatory bowel disease | Q46383587 | ||
| European consensus on the histopathology of inflammatory bowel disease. | Q46690820 | ||
| Genetic pathways in the evolution of morphologically distinct colorectal neoplasms | Q46848928 | ||
| Adenoma-like and non-adenoma-like dysplasia-associated lesion or mass in ulcerative colitis | Q46891587 | ||
| Hypermethylation of the p14(ARF) gene in ulcerative colitis-associated colorectal carcinogenesis. | Q48316942 | ||
| Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. | Q50714369 | ||
| Bowel inflammation as measured by fecal calprotectin: a link between lifestyle factors and colorectal cancer risk. | Q51029390 | ||
| Etheno DNA-base adducts from endogenous reactive species | Q33538101 | ||
| IKK/NF-kappaB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis | Q33561833 | ||
| WNT-pathway components as predictive markers useful for diagnosis, prevention and therapy in inflammatory bowel disease and sporadic colorectal cancer | Q33572324 | ||
| Mutations in TGFbeta-RII and BAX mediate tumor progression in the later stages of colorectal cancer with microsatellite instability | Q33611147 | ||
| Gene-gene and gene-environment interactions in ulcerative colitis. | Q33781693 | ||
| Oxyradicals and DNA damage | Q33846171 | ||
| Rectal nitric oxide as biomarker in the treatment of inflammatory bowel disease: responders versus nonresponders. | Q33867963 | ||
| From 'omics' to complex disease: a systems biology approach to gene-environment interactions in cancer | Q33875700 | ||
| Environmental risk factors for inflammatory bowel disease | Q33916393 | ||
| Red and processed meat and colorectal cancer incidence: meta-analysis of prospective studies | Q33932971 | ||
| The effect of appendectomy on the course of ulcerative colitis: a systematic review | Q33937309 | ||
| Appendectomy and protection against ulcerative colitis | Q33937912 | ||
| Mismatch repair polymorphisms and risk of colon cancer, tumour microsatellite instability and interactions with lifestyle factors | Q33990340 | ||
| Alcohol consumption and rectal tumor mutations and epigenetic changes | Q34007796 | ||
| The retinoblastoma gene: a prototypic and multifunctional tumor suppressor | Q34174294 | ||
| Genes and environment: how will our concepts on the pathophysiology of IBD develop in the future? | Q34307355 | ||
| Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease | Q34408295 | ||
| Nitric oxide-induced cellular stress and p53 activation in chronic inflammation | Q34466925 | ||
| COX-2: a target for colon cancer prevention | Q34504020 | ||
| Family history as a risk factor for colorectal cancer in inflammatory bowel disease | Q34514772 | ||
| Cytokines, NF-kappaB, microenvironment, intestinal inflammation and cancer. | Q34566447 | ||
| Tumor necrosis factor-alpha is a potent endogenous mutagen that promotes cellular transformation | Q34573460 | ||
| Ulcerative colitis-associated neoplasia. | Q34612321 | ||
| A cytokine-mediated link between innate immunity, inflammation, and cancer | Q34625152 | ||
| Ulcerative colitis and colorectal cancer. A population-based study | Q34634203 | ||
| Role of appendicitis and appendectomy in the pathogenesis of ulcerative colitis: a critical review. | Q34752303 | ||
| Familial predisposition for colorectal cancer in chronic ulcerative colitis: a case-control study | Q34754509 | ||
| Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes. | Q34779075 | ||
| Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies | Q34992075 | ||
| NF-kappaB activation in cancer: a challenge for ubiquitination- and proteasome-based therapeutic approach | Q35036569 | ||
| Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models | Q35094012 | ||
| Radical causes of cancer. | Q35097371 | ||
| Colitis-associated neoplasia: molecular basis and clinical translation | Q35169025 | ||
| Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study | Q35350584 | ||
| Villous, hypermucinous mucosa in long standing ulcerative colitis shows high frequency of K-ras mutations | Q35357501 | ||
| Environmental risk factors in paediatric inflammatory bowel diseases: a population based case control study | Q35597246 | ||
| DNA fingerprinting abnormalities can distinguish ulcerative colitis patients with dysplasia and cancer from those who are dysplasia/cancer-free | Q35748992 | ||
| Hsp10, Hsp70, and Hsp90 immunohistochemical levels change in ulcerative colitis after therapy | Q35771429 | ||
| Guidelines for the management of inflammatory bowel disease in adults | Q35790559 | ||
| K-ras mutations and p53 alterations in neoplastic and nonneoplastic lesions associated with longstanding ulcerative colitis | Q35833643 | ||
| Characterization of gene-environment interactions for colorectal cancer susceptibility loci | Q36030354 | ||
| Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease | Q36056597 | ||
| Interleukin-6: from basic science to medicine--40 years in immunology | Q36072403 | ||
| Gene-environment interactions in the etiopathogenesis of inflammatory bowel disease | Q36086797 | ||
| Cancer surveillance in ulcerative colitis | Q36202454 | ||
| CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer | Q36228506 | ||
| Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer | Q36243956 | ||
| Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease | Q36250322 | ||
| Inflammation and colorectal cancer: colitis-associated neoplasia | Q36597803 | ||
| Accumulation of mitochondrial DNA mutation with colorectal carcinogenesis in ulcerative colitis | Q36615139 | ||
| Appendicitis, mesenteric lymphadenitis, and subsequent risk of ulcerative colitis: cohort studies in Sweden and Denmark | Q37136968 | ||
| Cytokines: from gut inflammation to colorectal cancer | Q37160690 | ||
| The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer? | Q37174716 | ||
| Intestinal mucosal inflammation leads to systemic genotoxicity in mice | Q37259554 | ||
| Inflammatory bowel disease: pathogenesis | Q37454586 | ||
| NF-kappaB signaling pathway, inflammation and colorectal cancer. | Q37626897 | ||
| Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis | Q37660992 | ||
| Chronic inflammation and mutagenesis | Q37707521 | ||
| Overexpression of microRNAs-155 and 21 targeting mismatch repair proteins in inflammatory bowel diseases. | Q53260073 | ||
| Chronic psychosocial stress increases the risk for inflammation-related colon carcinogenesis in male mice. | Q53279547 | ||
| Role of different inflammatory and tumor biomarkers in the development of ulcerative colitis-associated carcinogenesis. | Q53296152 | ||
| A prostaglandin E2 receptor subtype EP1-selective antagonist, ONO-8711, suppresses 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis. | Q53340850 | ||
| Molecular pathogenesis of colorectal cancer: implications for molecular diagnosis. | Q53353721 | ||
| Low-grade dysplasia in extensive, long-standing inflammatory bowel disease: a follow-up study. | Q53390338 | ||
| Effects on sister chromatid exchange frequency of aldehyde dehydrogenase 2 genotype and smoking in vinyl chloride workers. | Q53428596 | ||
| The multifaceted roles of nitric oxide in cancer. | Q53433015 | ||
| Comparative analysis of histology, DNA content, p53 and Ki-ras mutations in colectomy specimens with long-standing ulcerative colitis. | Q53435738 | ||
| Genetic alterations in sporadic and Crohn's-associated adenocarcinomas of the small intestine. | Q53442180 | ||
| Microallelotyping defines the sequence and tempo of allelic losses at tumour suppressor gene loci during colorectal cancer progression. | Q53461627 | ||
| Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn's disease in children. | Q53774306 | ||
| Molecular alterations in chronic ulcerative colitis-associated and sporadic hyperplastic polyps: a comparative analysis. | Q54426452 | ||
| Telomere length in the colon declines with age: a relation to colorectal cancer? | Q54613758 | ||
| Serrated adenomas have a pattern of genetic alterations that distinguishes them from other colorectal polyps. | Q54642317 | ||
| Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1 | Q57240059 | ||
| Biomarker-based prediction of inflammatory bowel disease-related colorectal cancer: a case-control study | Q57259815 | ||
| The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases | Q57265429 | ||
| Vitamin D Status and Bone Density in Recently Diagnosed Inflammatory Bowel Disease: The Manitoba IBD Cohort Study | Q57711766 | ||
| Involvement of the serrated neoplasia pathway in inflammatory bowel disease-related colorectal oncogenesis | Q57785829 | ||
| Comparison of genetic alterations in colonic adenoma and ulcerative colitis-associated dysplasia and carcinoma | Q58053901 | ||
| Risk factors for colorectal cancer in patients with ulcerative colitis: A case-control study | Q58834128 | ||
| Prevalence of ras gene mutations in human colorectal cancers | Q59088716 | ||
| Rare CpG Island Methylator Phenotype in Ulcerative Colitis–Associated Neoplasias | Q63407619 | ||
| A transforming growth factor beta 1 receptor type II mutation in ulcerative colitis-associated neoplasms | Q63407691 | ||
| Microsatellite instability in the insulin–like growth factor II receptor gene in gastrointestinal tumours | Q63407701 | ||
| p53 Point mutations in dysplastic and cancerous ulcerative colitis lesions | Q63407707 | ||
| c-Ki-ras mutations in dysplastic fields and cancers in ulcerative colitis | Q67516622 | ||
| Loss of heterozygosity affecting the p53, Rb, and mcc/apc tumor suppressor gene loci in dysplastic and cancerous ulcerative colitis | Q67879474 | ||
| p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis | Q68623436 | ||
| Actions of sulfasalazine and 5-aminosalicylic acid as reactive oxygen scavengers in the suppression of bile acid-induced increases in colonic epithelial cell loss and proliferative activity | Q69897891 | ||
| Frequent loss of a p53 allele in carcinomas and their precursors in ulcerative colitis | Q70186500 | ||
| Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis | Q71102439 | ||
| Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy | Q71437311 | ||
| Serum nitrate levels in ulcerative colitis and Crohn's disease | Q71541501 | ||
| Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease | Q71591274 | ||
| Infrequent DPC4 gene mutation in esophageal cancer, gastric cancer and ulcerative colitis-associated neoplasms | Q71865193 | ||
| Molecular genetic profiles of colitis-associated neoplasms | Q72080054 | ||
| Microsatellite instability in ulcerative colitis-associated colorectal dysplasias and cancers | Q72149143 | ||
| Common occurrence of APC and K-ras gene mutations in the spectrum of colitis-associated neoplasias | Q72460708 | ||
| Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis | Q72840937 | ||
| High frequencies of telomeric associations, chromosome aberrations, and sister chromatid exchanges in ulcerative colitis | Q73009502 | ||
| Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors | Q73191057 | ||
| Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease | Q73335201 | ||
| Regenerative lesions in ulcerative colitis are characterized by microsatellite mutation | Q73501769 | ||
| Cancer risk in patients with inflammatory bowel disease: a population-based study | Q73592419 | ||
| Comparison of p53 immunoexpression with allelic loss of p53 in ulcerative colitis-associated dysplasia and carcinoma | Q74192775 | ||
| P433 | issue | 8 | |
| P921 | main subject | colorectal cancer | Q188874 |
| inflammatory bowel diseases | Q917447 | ||
| colorectal carcinoma | Q25493920 | ||
| P304 | page(s) | 2251-2263 | |
| P577 | publication date | 2015-04-04 | |
| P1433 | published in | Digestive Diseases and Sciences | Q15716711 |
| P1476 | title | Molecular Alterations of Colorectal Cancer with Inflammatory Bowel Disease | |
| P478 | volume | 60 |
| Q38970151 | APSA Awardee Submission: Tumor/cancer stem cell marker doublecortin-like kinase 1 in liver diseases |
| Q41816719 | Actions of probiotics on trinitrobenzenesulfonic acid-induced colitis in rats |
| Q93044698 | Bone marrow-derived CXCR4-overexpressing MSCs display increased homing to intestine and ameliorate colitis-associated tumorigenesis in mice |
| Q40397212 | Colorectal Cancer in Inflammatory Bowel Diseases: A Population-Based Study in Utah |
| Q39296522 | Evolution of Premalignant Disease. |
| Q55516972 | Genomic characterization of colitis-associated colorectal cancer. |
| Q91272449 | Immune-relevant aspects of murine models of head and neck cancer |
| Q57486990 | Increased Nuclear Factor-κB/RelA Expression Levels in Human Colorectal Carcinoma in North Indian Patients |
| Q91903963 | Inferring novel genes related to colorectal cancer via random walk with restart algorithm |
| Q50050206 | Long Noncoding RNA GAPLINC Promotes Cells Migration and Invasion in Colorectal Cancer Cell by Regulating miR-34a/c-MET Signal Pathway. |
| Q36531205 | Quince peel polyphenolic extract blocks human colon adenocarcinoma LS174 cell growth and potentiates 5-fluorouracil efficacy |
| Q37454003 | Risk factors for developing colorectal cancer in Japanese patients with ulcerative colitis: a retrospective observational study-CAPITAL (Cohort and Practice for IBD total management in Kyoto-Shiga Links) study I |
| Q37564565 | TES inhibits colorectal cancer progression through activation of p38. |
| Q38775276 | Targeted sequencing-based analyses of candidate gene variants in ulcerative colitis-associated colorectal neoplasia |
| Q90542917 | siRNA Delivery for Control of Cyclin D1 and E2F1 Expression in Crohn's Disease |
| Q94076162 | siRNA Delivery for Control of Cyclin D1 and E2F1 Expression in Crohn's Disease |
Search more.